|
|
xi | |
|
|
1 | (18) |
|
GLPs and Nonclinical Studies |
|
|
4 | (2) |
|
CROs and Nonclinical Studies |
|
|
6 | (2) |
|
|
8 | (1) |
|
|
9 | (8) |
|
|
9 | (1) |
|
|
10 | (2) |
|
|
12 | (1) |
|
|
13 | (2) |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
17 | (2) |
|
2 Good Laboratory Practices |
|
|
19 | (40) |
|
US FDA (21 CFR Part 58) and OECD GLPs |
|
|
22 | (1) |
|
Subpart A General Provisions |
|
|
23 | (2) |
|
Section 58.3 (Definitions) |
|
|
23 | (2) |
|
Section 58.10 (Applicability to Studies Performed Under Grants and Contracts) |
|
|
25 | (1) |
|
Section 58.15 (Inspection of a Testing Facility) |
|
|
25 | (1) |
|
Subpart B Organization and Personnel |
|
|
25 | (4) |
|
Section 58.29 (Personnel) |
|
|
26 | (1) |
|
Computer Systems (21 CFR Part 11) |
|
|
26 | (1) |
|
Section 58.31 (Testing Facility Management) |
|
|
26 | (1) |
|
Section 58.33 (Study Director) |
|
|
27 | (1) |
|
|
27 | (2) |
|
|
29 | (1) |
|
|
29 | (1) |
|
Section 58.43 (Animal Care Facilities) |
|
|
29 | (1) |
|
Section 58.45 (Animal Supply Facilities) |
|
|
30 | (1) |
|
Section 58.47 (Facilities for Handling Test and Control Articles) |
|
|
30 | (1) |
|
Section 58.49 (Laboratory Operation Areas) |
|
|
30 | (1) |
|
Section 58.51 (Specimen and Data Storage Facilities) |
|
|
30 | (1) |
|
|
30 | (1) |
|
Section 58.61 (Equipment Design) |
|
|
30 | (1) |
|
Section 58.63 (Maintenance and Calibration of Equipment) |
|
|
31 | (1) |
|
Computer Systems (21 CFR Part 11) |
|
|
31 | (1) |
|
Subpart E Testing Facilities Operation |
|
|
31 | (3) |
|
Section 58.81 (Standard Operating Procedures [ SOPs]) |
|
|
31 | (1) |
|
Section 58.83 (Reagents and Solutions) |
|
|
32 | (1) |
|
Section 58.90 (Animal Care) |
|
|
33 | (1) |
|
Subpart F Test and Control Articles |
|
|
34 | (1) |
|
Section 58.105 (Test and Control Article Characterization) |
|
|
34 | (1) |
|
Section 58.107 (Test and Control Article Handling) |
|
|
34 | (1) |
|
Section 58.113 (Mixtures of Articles with Carriers) |
|
|
35 | (1) |
|
Subpart G Protocol for and Conduct of a Nonclinical Laboratory Study |
|
|
35 | (2) |
|
Section 58.120 (Protocol) |
|
|
35 | (1) |
|
Section 58.130 (Conduct of a Nonclinical Laboratory Study) |
|
|
36 | (1) |
|
Subpart J Records and Reports |
|
|
37 | (3) |
|
Section 58.185 (Reporting of Nonclinical Laboratory Study Results) |
|
|
37 | (1) |
|
Section 58.190 (Storage and Retrieval of Records and Data) |
|
|
38 | (1) |
|
Section 58.195 (Retention of Records) |
|
|
38 | (2) |
|
|
40 | (2) |
|
European Union (EU) Facility Inspections |
|
|
42 | (1) |
|
|
42 | (17) |
|
|
59 | (22) |
|
General Study Design Issues |
|
|
61 | (12) |
|
Animal Procurement and Selection |
|
|
61 | (1) |
|
Quarantine and Pre-Study Health Assessment |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
68 | (2) |
|
|
70 | (3) |
|
|
73 | (1) |
|
|
73 | (8) |
|
|
81 | (22) |
|
|
84 | (8) |
|
Regulations Established by the USDA Under the AWA |
|
|
92 | (1) |
|
Potential Conflicts Between the Animal Welfare Requirements, GLPs, and Other Study Requirements |
|
|
93 | (1) |
|
|
94 | (9) |
|
|
103 | (18) |
|
Contacting and Preliminary Screening of a New Laboratory |
|
|
104 | (4) |
|
Meeting with a Sales and/or Technical Representative |
|
|
105 | (3) |
|
Visiting and Auditing a New Laboratory |
|
|
108 | (7) |
|
Laboratory Selection Checklist |
|
|
115 | (6) |
|
|
121 | (16) |
|
|
122 | (9) |
|
|
131 | (1) |
|
Detailed Study Outline Template |
|
|
132 | (5) |
|
7 Contracts and Business Ethics |
|
|
137 | (12) |
|
|
137 | (2) |
|
|
139 | (3) |
|
Maintaining Confidentiality During the Study |
|
|
142 | (2) |
|
|
144 | (1) |
|
Example of a Confidential Disclosure Agreement |
|
|
145 | (4) |
|
8 Study Protocol Preparation, Review, and Approval |
|
|
149 | (24) |
|
|
150 | (1) |
|
Reviewing the Draft Protocol |
|
|
151 | (18) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
153 | (2) |
|
Submission of Study to Regulatory Authorities |
|
|
155 | (1) |
|
Test and Control Articles |
|
|
155 | (1) |
|
|
156 | (3) |
|
|
159 | (1) |
|
Test and Control Article Administration |
|
|
159 | (2) |
|
In-Life Study Evaluations |
|
|
161 | (3) |
|
|
164 | (1) |
|
|
164 | (2) |
|
|
166 | (1) |
|
|
166 | (1) |
|
Records and Specimen Retention |
|
|
166 | (1) |
|
Compliance with Animal Welfare Regulations |
|
|
166 | (1) |
|
|
167 | (2) |
|
|
169 | (1) |
|
Changing the Finalized Protocol |
|
|
170 | (1) |
|
|
171 | (2) |
|
|
173 | (8) |
|
Test and Control Article Synthesis and Sourcing |
|
|
173 | (2) |
|
Test and Control Article Characterization |
|
|
175 | (1) |
|
Mixtures of Test Articles |
|
|
176 | (2) |
|
Test Article and Mixture Receipt, Storage, and Tracking |
|
|
178 | (1) |
|
Additional Considerations |
|
|
179 | (2) |
|
10 Study Start Through End of In-Life |
|
|
181 | (12) |
|
Test Article and Formulations |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
184 | (2) |
|
Protocol Deviations and Amendments |
|
|
186 | (2) |
|
Study Updates, Data Auditing, and GLP Compliance |
|
|
188 | (2) |
|
|
190 | (3) |
|
11 Study Communication and Data Management |
|
|
193 | (12) |
|
Handling Issues That May Arise |
|
|
194 | (1) |
|
|
195 | (2) |
|
Study Reports and Archiving |
|
|
197 | (1) |
|
Communicating Study Results |
|
|
198 | (5) |
|
|
203 | (2) |
|
12 A Study Director's Perspective on Study Monitor-Study Director Interactions |
|
|
205 | (12) |
|
Establishing the Working Relationship |
|
|
205 | (1) |
|
Setting Your Expectations |
|
|
206 | (1) |
|
The Study Director's Expectations of You |
|
|
207 | (2) |
|
Pre-Protocol Communications |
|
|
209 | (1) |
|
|
210 | (1) |
|
|
211 | (1) |
|
|
212 | (1) |
|
|
213 | (1) |
|
Study Issues and the Unexpected |
|
|
213 | (2) |
|
|
213 | (1) |
|
Unexpected or Severe Toxicity |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (1) |
|
|
216 | (1) |
|
|
217 | (20) |
|
|
218 | (2) |
|
|
218 | (1) |
|
|
218 | (1) |
|
|
219 | (1) |
|
Receiving the Draft Report |
|
|
220 | (14) |
|
Keeping Track of Changes and Comments |
|
|
220 | (2) |
|
Quality Assurance Unit Review |
|
|
222 | (1) |
|
Scientific and Quality Control Review |
|
|
223 | (11) |
|
Sending Comments to the Laboratory |
|
|
234 | (2) |
|
|
236 | (1) |
|
14 Final Report, Study Close-Out, and Conclusions |
|
|
237 | (4) |
|
|
237 | (2) |
|
Amending the Final Report |
|
|
239 | (1) |
|
|
239 | (1) |
|
|
240 | (1) |
Index |
|
241 | |